CNSP (CNS Pharmaceuticals) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNSP CNS Pharmaceuticals Inc CNSP
35 GF Score
Price $5.80
! 1 Warning Sign
View Full Analysis

What is CNS Pharmaceuticals Net Loan?

Net Loan only applies to banks and insurance companies.

CNSP
35GF Score
CNS Pharmaceuticals Inc CNSP
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CNS Pharmaceuticals Business Description

Address 2100 West Loop South, Suite 900, Houston, TX, USA, 77027
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
35GF Score

Get the complete analysis for CNSP

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.80
Price